Due to trouble in sales activities, sales promotion expenses of listed pharmaceutical companies have decreased

As pharmaceutical companies are having trouble on sales activities due to intension of the rebate restriction, it seems that sales promotion expenses tend to decrease as well.

According to the YakupDotCom’s analysis result of 2014 audit reports that KOSPI and KOSDAQ listed pharmaceutical companies finalized on December turned in to the Financial Supervisory Service, rates of sales promotion ex...